BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3828712)

  • 1. Flutamide as primary treatment for metastatic prostatic cancer.
    Lundgren R
    Br J Urol; 1987 Feb; 59(2):156-8. PubMed ID: 3828712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide in the treatment of metastatic carcinoma of the prostate.
    Narayana AS; Loening SA; Culp DA
    Br J Urol; 1981 Apr; 53(2):152-3. PubMed ID: 7237048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
    Sogani PC; Vagaiwala MR; Whitmore WF
    Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
    Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
    Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide therapy for advanced prostatic cancer: a phase II study.
    MacFarlane JR; Tolley DA
    Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide--an antiandrogen inhibiting prostatic cancer and prostatic secretion with retention of potency.
    Stegmayr B; Johansson JE; Schnürer LB
    Med Oncol Tumor Pharmacother; 1988; 5(1):61-5. PubMed ID: 3367673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
    Sogani PC; Whitmore WF
    J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
    Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
    Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
    Scher HI; Liebertz C; Kelly WK; Mazumdar M; Brett C; Schwartz L; Kolvenbag G; Shapiro L; Schwartz M
    J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
    Lund F; Rasmussen F
    Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of flutamide in the treatment of carcinoma of the prostate stages C and D (T3-T4, Nx-N0, M0-M1 categories)].
    Daricello G; Caramia G; Rizzo FP; Serretta V; Di Trapani D; Pavone-Macaluso M
    Minerva Urol Nefrol; 1986; 38(1):71-6. PubMed ID: 3738681
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
    de Kernion JN; Murphy GP; Priore R
    Urology; 1988 Apr; 31(4):312-7. PubMed ID: 3281365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
    Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation with long-term follow-up of flutamide and estramustine as initial treatment of metastatic carcinoma of the prostate.
    Johansson JE; Andersson SO; Beckman KW; Zador G
    Am J Clin Oncol; 1988; 11 Suppl 2():S183-6. PubMed ID: 3242386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flutamide therapy for carcinoma of the prostate.
    Airhart RA; Barnett TF; Sullivan JW; Levine RL; Schlegel JU
    South Med J; 1978 Jul; 71(7):798-801. PubMed ID: 78529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
    Miyake H; Hara I; Eto H
    BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flutamide in the treatment of advanced carcinoma of the prostate].
    Vomácka V; Vachalovský V
    Rozhl Chir; 1985 Nov; 64(11):723-8. PubMed ID: 4089703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.